Since MSCs do not express the CD45 marker, marked increase of CD45+ and CD45+CD11b+Ly6G− mononuclear populations in the tumor microenvironment confirmed the immune modulating functions of MSCs. This evidence concerns the gene PTPRC and neoplasm.